[ Price : $8.95]
A new FDA literature review on dental amalgam safety finds no sufficient evidence of a relationship between clinically detectable ...[ Price : $8.95]
Federal Register notice: FDA announces the fee rate of $2,167,116 for using a pediatric disease priority review voucher for fiscal...[ Price : $8.95]
Federal Register notice: FDA announces the fee rate of $2,167,116 for using a material threat medical countermeasure priority revi...[ Price : $8.95]
The government charges Avanir Pharmaceuticals and four individuals for paying kickbacks to a physician to induce prescribing of it...[ Price : $8.95]
FDA posts a draft guidance on Patient-Focused Drug Development: Methods to Identify What Is Important to Patients.[ Price : $8.95]
Federal Register notice: FDA makes available a final guidance on Changes to Existing Medical Software Policies Resulting From Sect...[ Price : $8.95]
CDERs Office of Prescription Drug Promotion cites a Kowa Pharmaceuticals America direct-to-consumer patient testimonial video mont...[ Price : $8.95]
Federal Register notice: FDA makes available a draft guide on demonstrating bioequivalence for soluble powder oral dosage form pro...